pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2009-0-1-83-89pulmo-1740Research ArticleОБЗОРЫREVIEWСаркоидоз: обзор работ последних летSarcoidosis: review of recent knowledgeВизельА. А.ViselA. A.
Визель Александр Андреевич – д. м. н., проф., зав. кафедрой фтизиопульмонологии
420012, Казань, ул. Бутлерова, 49
тел.: (843) 272-16-61
lordara@mail.ruГОУ ВПО "Казанский медицинский университет" РосздраваRussian Federation200928022009018389Copyright © Визель А.А., 20092009Визель А.А.Visel A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/1740
.
.
саркоидозферментыхемокиныфункция внешнего дыханиякачество жизниглюкокортикостероидыальтернативные методы леченияsarcoidosisenzymeschemokineslung functionquality of lifecorticosteroidsalternative treatmentReferencesHunninghake G.W., Costabel U., Ando M. et al. Statement on sarcoidosis. Sarcoidos. Vasc. Diffuse Lung Dis. 1999; 16: 149–173.Hunninghake G.W., Costabel U., Ando M. et al. Statement on sarcoidosis. Sarcoidos. Vasc. Diffuse Lung Dis. 1999; 16: 149–173.Drent M., Costabel U. (eds.). Sarcoidosis. Eur. Respir. Mon. 2005; 10: Monograph 32.Drent M., Costabel U. (eds.). Sarcoidosis. Eur. Respir. Mon. 2005; 10: Monograph 32.Визель А.А. (ред.). Саркоидоз: от гипотезы к практике. Казань: Изд-во "Фэн"; 2004.Визель А.А. (ред.). Саркоидоз: от гипотезы к практике. Казань: Изд-во "Фэн"; 2004.Борисов С.Е., Соловьева И.П., Ефимьевский В.П. и др. Диагностика и лечение саркоидоза органов дыхания (пособие для фтизиатров и пульмонологов). Пробл. туб. 2003; 6: 51–64.Борисов С.Е., Соловьева И.П., Ефимьевский В.П. и др. Диагностика и лечение саркоидоза органов дыхания (пособие для фтизиатров и пульмонологов). Пробл. туб. 2003; 6: 51–64.Шмелев Е.И. Саркоидоз. Атмосфера: Пульмонол. и аллергол. 2004; 2 (13): 3–10.Шмелев Е.И. Саркоидоз. Атмосфера: Пульмонол. и аллергол. 2004; 2 (13): 3–10.Gogali A., Matthaiou M., Margelis I. et al. Interferon-γ released assay (IGRA) in Greek patients with sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. E2851.Gogali A., Matthaiou M., Margelis I. et al. Interferon-γ released assay (IGRA) in Greek patients with sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. E2851.Bargagli E., Mazzi A., Mezzasalma F. et al. The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. P1872.Bargagli E., Mazzi A., Mezzasalma F. et al. The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. P1872.Bargagli E., Bianchi N., Olivieri C. et al. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. 3173.Bargagli E., Bianchi N., Olivieri C. et al. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. 3173.Cui A., Anhenn A.,Theegarten D. et al. Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P1877.Cui A., Anhenn A.,Theegarten D. et al. Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P1877.Kriegova E., Fillerova R., Arakelyan A. et al. Chemokine mRNA expression profiling in pulmonary sarcoidosis. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. 200.Kriegova E., Fillerova R., Arakelyan A. et al. Chemokine mRNA expression profiling in pulmonary sarcoidosis. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. 200.Svendsen C.B., Hummelshoj T., Munthe-Fog L. et al. Ficolins and mannose-binding lectin in Danish patients with sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3172.Svendsen C.B., Hummelshoj T., Munthe-Fog L. et al. Ficolins and mannose-binding lectin in Danish patients with sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3172.Kieszko R., Chocholska S., Krawczyk P. TNF-alpha and TNF-beta gene polymorphism in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3169.Kieszko R., Chocholska S., Krawczyk P. TNF-alpha and TNF-beta gene polymorphism in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3169.Veltkamp M., Grutters J., van Moorsel C. et al. A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 199.Veltkamp M., Grutters J., van Moorsel C. et al. A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 199.Cervis L., Teleaga C., Ionita D. et al. The reflection of the ventilatory dysfunction by the bronchoalveolar lavage cytological pattern in newly diagnosed sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3441.Cervis L., Teleaga C., Ionita D. et al. The reflection of the ventilatory dysfunction by the bronchoalveolar lavage cytological pattern in newly diagnosed sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3441.Vucinic V., Zugic V., Filipovic S. et al. Sarcoidosis: depression and negative life events in patients with different course of the disease. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3447.Vucinic V., Zugic V., Filipovic S. et al. Sarcoidosis: depression and negative life events in patients with different course of the disease. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3447.Moffat M., Cleland J., Qi X., Dempsey O. An exploration of coping strategies and quality of life in sarcoidosis patients. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3449.Moffat M., Cleland J., Qi X., Dempsey O. An exploration of coping strategies and quality of life in sarcoidosis patients. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3449.Moffat M., Cleland J., Xiaojiu Q., Dempsey O. An exploration of illness perceptions in sarcoidosis patients. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3448.Moffat M., Cleland J., Xiaojiu Q., Dempsey O. An exploration of illness perceptions in sarcoidosis patients. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3448.Kukol P., Jonner I., Oravec P. et al. Sarcoidosis of pleura. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3440.Kukol P., Jonner I., Oravec P. et al. Sarcoidosis of pleura. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3440.Liman S., Topcu S., Burc K., Elicora A. Two similar but very different cases: coexistence of lung carcinoma and sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P2150.Liman S., Topcu S., Burc K., Elicora A. Two similar but very different cases: coexistence of lung carcinoma and sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P2150.Milman N., Svendsen C.B., Hoffmann A.L. Childhood sarcoidosis in Denmark: long term follow-up of 46 children. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3438.Milman N., Svendsen C.B., Hoffmann A.L. Childhood sarcoidosis in Denmark: long term follow-up of 46 children. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3438.Macedo P., Coker R.K., Partridge M.R. Is there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise. BMC Pulm. Med. 2007; 13: 3.Macedo P., Coker R.K., Partridge M.R. Is there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise. BMC Pulm. Med. 2007; 13: 3.Ionita D., Cilt C., Tudose C. et al. Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P586.Ionita D., Cilt C., Tudose C. et al. Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P586.Coker R.K. Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs 2007; 67: 1139–1147.Coker R.K. Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs 2007; 67: 1139–1147.Baughman R.P., Costabel U., du Bois R.M. Treatment of sarcoidosis. Clin. Chest. Med. 2008; 29: 533–548.Baughman R.P., Costabel U., du Bois R.M. Treatment of sarcoidosis. Clin. Chest. Med. 2008; 29: 533–548.Jindal S.K. Practical issues and challenges in the diagnosis and treatment of pulmonary sarcoidosis. Drugs 2007; 67: 17–26.Jindal S.K. Practical issues and challenges in the diagnosis and treatment of pulmonary sarcoidosis. Drugs 2007; 67: 17–26.Markart P., Seeger W., Guјnther A. Differential therapy of pulmonary fibrosis. Internist (Berl.) 2006; 47 (suppl. 1): 26–32.Markart P., Seeger W., Guјnther A. Differential therapy of pulmonary fibrosis. Internist (Berl.) 2006; 47 (suppl. 1): 26–32.Baradina H., Kamishnikov V. Essential phospholipids in pulmonary sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3434.Baradina H., Kamishnikov V. Essential phospholipids in pulmonary sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. P3434.Tahanovich A.D., Katovich I.L., Baradina H.L. The evaluation of oxygen-activating function of mononuclear phagocytes in sarcoidosis. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. P3435.Tahanovich A.D., Katovich I.L., Baradina H.L. The evaluation of oxygen-activating function of mononuclear phagocytes in sarcoidosis. Europ. Respir. J. 2008; 32 (suppl. 52): Ref. P3435.Hostettler K., Baty F., Studler U. et al. Infliximab therapy in patients with chronic progressive sarcoidosis – a retrospective follow-up study. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3175.Hostettler K., Baty F., Studler U. et al. Infliximab therapy in patients with chronic progressive sarcoidosis – a retrospective follow-up study. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3175.English S., Choo-Kang B., Menzies F. et al. The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3174.English S., Choo-Kang B., Menzies F. et al. The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis. Eur. Respir. J. 2008; 32 (suppl. 52): Ref. 3174.Frangova Youroukova V., Ivanov St., Popov G. Chlamydia pneumoniae and respiratory tract diseases in Bulgaria. Eur. Respir. J. 1997; 10 (suppl. 25): Ref. 2096.Frangova Youroukova V., Ivanov St., Popov G. Chlamydia pneumoniae and respiratory tract diseases in Bulgaria. Eur. Respir. J. 1997; 10 (suppl. 25): Ref. 2096.Bachelez H., Senet P., Cadranel J. et al. The use of tetracyclines for the treatment of sarcoidosis. Arch. Dermatol. 2001; 137: 69–73.Bachelez H., Senet P., Cadranel J. et al. The use of tetracyclines for the treatment of sarcoidosis. Arch. Dermatol. 2001; 137: 69–73.Marshall T.G., Marshall F.E. Sarcoidosis succumbs to antibiotics-implications for autoimmune disease. Autoimmun. Rev. 2004; 3: 295–300.Marshall T.G., Marshall F.E. Sarcoidosis succumbs to antibiotics-implications for autoimmune disease. Autoimmun. Rev. 2004; 3: 295–300.Lun K.R., Wood D.J., Muir J.B., Noakes R. Granulomas in common variable immunodeficiency: A diagnostic dilemma. Australas. J. Dermatol. 2004; 45: 51–54.Lun K.R., Wood D.J., Muir J.B., Noakes R. Granulomas in common variable immunodeficiency: A diagnostic dilemma. Australas. J. Dermatol. 2004; 45: 51–54.Baba K., Yamaguchi E., Matsui S. et al. A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. Sarcoidos. Vasc. Diffuse Lung Dis. 2006; 23: 78–79.Baba K., Yamaguchi E., Matsui S. et al. A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. Sarcoidos. Vasc. Diffuse Lung Dis. 2006; 23: 78–79.Турлай Е.А., Логвиненко Н.И. Саркоидоз органов дыхания: клиника и течение. Урал. мед. журн. 2008; Прил.: Сборник трудов XVIII Национального конгресса по болезням органов дыхания: 133, реф. 316.Турлай Е.А., Логвиненко Н.И. Саркоидоз органов дыхания: клиника и течение. Урал. мед. журн. 2008; Прил.: Сборник трудов XVIII Национального конгресса по болезням органов дыхания: 133, реф. 316.Богданова Ю.В., Мищенко О.В., Артамонов И.Д. и др. Возможности медицинской помощи больным саркоидозом в Самарской области. Урал. мед. журн. 2008; Прил.: Сборник трудов XVIII Национального конгресса по болезням органов дыхания: 133–134, реф. 318.Богданова Ю.В., Мищенко О.В., Артамонов И.Д. и др. Возможности медицинской помощи больным саркоидозом в Самарской области. Урал. мед. журн. 2008; Прил.: Сборник трудов XVIII Национального конгресса по болезням органов дыхания: 133–134, реф. 318.
The authors declare that there are no conflicts of interest present.